Next Article in Journal
Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
Next Article in Special Issue
The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme
Previous Article in Journal / Special Issue
High Vitamin C Status Is Associated with Elevated Mood in Male Tertiary Students
Open AccessCase Report

Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia

1
Integrated Health Options Ltd., Auckland 1050, New Zealand
2
Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand
3
Feedback Research Ltd., Auckland 1050, New Zealand
*
Author to whom correspondence should be addressed.
Antioxidants 2018, 7(7), 92; https://doi.org/10.3390/antiox7070092
Received: 8 June 2018 / Revised: 10 July 2018 / Accepted: 12 July 2018 / Published: 16 July 2018
(This article belongs to the Special Issue Vitamin C: Current Concepts in Human Physiology)
A 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014). Intravenous(IV) vitamin C therapy was initiated (in 2014) following completion of chemotherapy as an alternative to haematopoietic stem cell transplantation. IV vitamin C was administered twice weekly at a dose of 70 g/infusion. Within 4 weeks of initiation of IV vitamin C therapy, there was a dramatic improvement in the patient’s blood indices with platelet cell counts increasing from 25 × 109/L to 196 × 109/L and white blood cell counts increasing from 0.29 × 109/L to 4.0 × 109/L, with further improvements observed over the next 18 months. Furthermore, there was a clear and sustained improvement in the patient’s health-related quality of life scores assessed using a validated questionnaire. She has remained healthy and in complete remission until the present day. This case study highlights the benefits of IV vitamin C as a supportive therapy for previously relapsed AML. View Full-Text
Keywords: vitamin C; intravenous vitamin C; leukemia; acute myeloid leukemia; AML vitamin C; intravenous vitamin C; leukemia; acute myeloid leukemia; AML
Show Figures

Figure 1

MDPI and ACS Style

Foster, M.N.; Carr, A.C.; Antony, A.; Peng, S.; Fitzpatrick, M.G. Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia. Antioxidants 2018, 7, 92. https://doi.org/10.3390/antiox7070092

AMA Style

Foster MN, Carr AC, Antony A, Peng S, Fitzpatrick MG. Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia. Antioxidants. 2018; 7(7):92. https://doi.org/10.3390/antiox7070092

Chicago/Turabian Style

Foster, Mike N.; Carr, Anitra C.; Antony, Alina; Peng, Selene; Fitzpatrick, Mike G. 2018. "Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia" Antioxidants 7, no. 7: 92. https://doi.org/10.3390/antiox7070092

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop